This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Beyond the Joint: Managing the Impact of Comorbidities in RA

Beyond the Joint: Managing the Impact of Comorbidities in RA

Format

Patient Case Study

Time to Complete

1 hour

Released

May 2, 2016

Expires

May 2, 2017
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

Jointly provided by

Commercial Supporter

This activity is supported by an independent educational grant from Pfizer.

Program Description

The successful management of the extra-articular effects of rheumatoid arthritis (RA) in patients with comorbidities is a considerable clinical challenge. The occurrence of depression and cardiovascular disease (CVD), in particular, is disproportionately increased in RA patients—profoundly influencing the course and greatly complicating the management of this disease.

This Virtual Practice presents two RA patients whose cases are complicated by the development of comorbidities. Your challenge is to assess these patients and develop appropriate treatment plans.

  • Case 4: A Case of Established RA and Other Health Concerns
    Lorraine, 57, has active RA and a history of questionable medication adherence. She’s recently experienced chest pain and overall fatigue. Given Lorraine’s stubborn smoking habit and family history of CVD, determining an appropriate, effective management plan is not going to be straightforward…
  • Case 5: RA Patient With Moderate Disease Activity and Increasing Pain and Fatigue
    Stanley, 60, has had RA for 12 years that’s been generally under control. Lately, Stanley has experienced fatigue, worsening pain, and increasing periods of morning stiffness. Could rumors of layoffs at his office be leading to his worsening symptoms?

The Virtual Practice Resource Library houses tools that can aid in the assessment and management of RA patients who have or are at risk for comorbid conditions.

Intended Audience

This activity has been designed to meet the educational needs of rheumatologists and other clinicians who provide care to patients with RA.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Describe how cardiovascular disease (CVD) and depression associated with RA influence disease course and management
  • Implement current recommendations for identifying and managing CVD and depression associated with RA

Conflict Of Interest Disclosure Policy

The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Faculty

Joel M. Kremer, MD—Program Chair
Pfaff Family Professor of Medicine
Albany Medical College
Director of Research
The Center for Rheumatology
Albany, NY

Dr. Kremer has disclosed the following relevant financial relationships:
Consultant: AbbVie, Amgen, Bristol-Myers Squibb, Genentech, Lilly, Pfizer
Research: AbbVie, Lilly, Novartis
Salary/Ownership Interest: Corrona
Speakers Bureau: Genentech

Dr. Kremer has indicated that his relationships will not impact his ability to author an unbiased presentation.

Jeffrey D. Greenberg, MD, MPH
Clinical Associate Professor of Medicine
New York University School of Medicine
New York, NY

Dr. Greenberg has disclosed the following relevant financial relationships:
Consultant: Janssen, Novartis
Research Grant: AbbVie, Amgen, Eli Lilly, Genentech, Janssen, Pfizer, UCB
Salary/Ownership Interest: Corrona

Dr. Greenberg has indicated that his relationships will not impact his ability to author an unbiased presentation.

Eric M. Ruderman, MD
Professor of Medicine
Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Faculty Foundation
Chicago, IL

Dr. Ruderman has disclosed the following relevant financial relationships:
Consultant: AbbVie, Amgen, Janssen, Lilly, Medac, Novartis, Pfizer
Research: AbbVie, AbGenomics, Amgen, Lilly, Novartis

Dr. Ruderman has indicated that his relationships will not impact his ability to author an unbiased presentation.

Peer Reviewer
Chaim Putterman, MD

Professor, Department of Medicine (Rheumatology)
Professor, Department of Microbiology & Immunology
Albert Einstein College of Medicine
Chief, Division of Rheumatology, Department of Medicine
Montefiore Medical Center
Bronx, NY

Dr. Putterman has disclosed that he does not have any relevant financial relationships.

Planning Committee

Victor B. Hatcher, PhD, and the staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine have no conflict of interest with commercial interests related directly or indirectly to this educational activity.

RedMedEd
Denise C. LaTemple, PhD
, Director of Scientific Services, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
Karen Smith, Creative Director, has disclosed no relevant financial relationships.
Barbara Zosh, Director of Operations, has disclosed no relevant financial relationships.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and RedMedEd. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Albert Einstein College of Medicine, RedMedEd, and Pfizer do not recommend the use of any agent outside the labeled indications.

The faculty have indicated that this enduring material does not include discussion of the unlabeled/investigational use of a commercial product or device.

Disclaimer

The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, Montefiore Medical Center, RedMedEd, or Pfizer. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Instructions

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CME credit for participation, participants must complete the posttest (achieving a passing grade of 75% or greater) and program evaluation. Certificates can be printed immediately.

If you have questions about this CME activity, please contact Albert Einstein College of Medicine at (718) 920-6674 or cme@montefiore.org.

For technical questions related to this activity, please contact RedMedEd at (610) 251-6841 or education@redmeded.com.

Copyright

Copyright © 2016 Albert Einstein College of Medicine and RedMedEd. All rights reserved. No part of this material may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations.
Add to Queue